EUVIMEDEUVIMED entdecken
Crossref

Impact of sodium glucose cotransporter-2 inhibitors on heart failure morbidity and readmission rates: An observational descriptive study

Armand Penge Okamba, Fatiha Yahia Ait, Catherine Petit, François Koukoui, Pascal Goube, Brahim Meftout, Jean Robert Rissassi Makulo, Pascal Mwasa Bayauli, Fabien Mbala Kintoki, Cyriaque Agavoedo, Victor Buzur, Diane Bado und 6 weitere

Annales Africaines de Medecine · 29.04.2026 · 19 (2) · e6905-e6914

DOI: 10.4314/aamed.v19i2.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Africaines de Medecine, online erschienen am 29.04.2026. Verfasst von Armand Penge Okamba und 17 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context and objective. Heart failure (HF) represents a major and growing public health burden in developed countries, including France, due to its high associated costs and frequent rehospitalizations. This study aimed to evaluate the impact of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) on morbidity and rehospitalization in patients with HF.

Methods

We conducted a retrospective and descriptive case series study at the Sud Francilien Hospital Center from January 1, 2020, to December 31, 2023. We collected comprehensive data on sociodemographics, clinical characteristics (medical history and HF specifics), laboratory markers, echocardiographic findings, and treatement details to assesses whether SGLT-2i use was associated with a reduction in HF-related hospital readmissions.

Results

Among the 160 patients (mean age 71 ± 16 years) hospitalized for HF, 95 (59.4%) did not receive SGLT-2i, and 67 (70.5%) of them were readmitted. Out of 65 patients treated with gliflozins, only 11 (17%) were readmitted. The use of SGLT-2i inhibitors was associated with a reduction in hospitalizations. Not receiving SGLT-2 inhibitors increased the risk of readmission by 3.6-fold (95% CI : 1.87-6,83, p

Zitieren

APA

Okamba, A. P., Ait, F. Y., Petit, C., Koukoui, F., Goube, P., Meftout, B., Makulo, J. R. R., Bayauli, P. M., Kintoki, F. M., Agavoedo, C., Buzur, V., Bado, D., Kasongo, A. M., Tchoufag, T., Kianga, J. P., Ablawa, A. A., Kat, F. K., & Buila, N. B. (2026). Impact of sodium glucose cotransporter-2 inhibitors on heart failure morbidity and readmission rates: An observational descriptive study. Annales Africaines de Medecine, 19(2), e6905-e6914. https://doi.org/10.4314/aamed.v19i2.11

Vancouver

Okamba AP, Ait FY, Petit C, Koukoui F, Goube P, Meftout B, et al. Impact of sodium glucose cotransporter-2 inhibitors on heart failure morbidity and readmission rates: An observational descriptive study. Annales Africaines de Medecine. 2026;19(2):e6905-e6914. doi:10.4314/aamed.v19i2.11

BibTeX
@article{Okamba2026,
  author = {Okamba, Armand Penge and Ait, Fatiha Yahia and Petit, Catherine and Koukoui, François and Goube, Pascal and Meftout, Brahim and Makulo, Jean Robert Rissassi and Bayauli, Pascal Mwasa and Kintoki, Fabien Mbala and Agavoedo, Cyriaque and Buzur, Victor and Bado, Diane and Kasongo, Adolphe Mukombola and Tchoufag, Théophile and Kianga, Jean Pierre and Ablawa, Akpé Adzodo and Kat, Fortunat Kabongo and Buila, Nathan Bimbi},
  title = {Impact of sodium glucose cotransporter-2 inhibitors on heart failure morbidity and readmission rates: An observational descriptive study},
  journal = {Annales Africaines de Medecine},
  year = {2026},
  volume = {19},
  number = {2},
  pages = {e6905--e6914},
  doi = {10.4314/aamed.v19i2.11}
}
Kostenlos starten →